For citations:
Sychevskaya K.A., Kravchenko S.K. Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra. Oncohematology. 2022;17(2):95-106. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-2-95-106
Sychevskaya K.A., Kravchenko S.K. Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra. Oncohematology. 2022;17(2):95-106. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-2-95-106